One health (Amsterdam, Netherlands) · 2026
Beyond the eschar: African tick-bite fever in a returning traveller - a diagnostic and public health consideration in Europe.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bogacka Anna, Baranowicz Karolina, Grzybek Maciej
Аннотация
BACKGROUND: African tick-bite fever (ATBF), caused by Rickettsia africae, is the most common tick-borne rickettsiosis among travellers returning from sub-Saharan Africa. In non-endemic regions, its relevance lies mainly in diagnostic challenges in returning travellers and the need for continued vigilance in vector-borne disease surveillance.
CASE PRESENTATION: report a 48-year-old woman presenting with fever, headache, myalgia, abdominal pain, and multiple eschars after a 9-day trip to South Africa. Clinical examination revealed fever (38.5 °C), tender inguinal lymphadenopathy, and a maculopapular rash. Laboratory findings showed elevated C-reactive protein (45.4 mg/L) and mild monocytosis. Molecular analysis of eschar samples detected Rickettsia DNA, subsequently identified as R. africae. The patient was treated with oral doxycycline (200 mg/day) with rapid clinical improvement.
DISCUSSION: ATBF remains underrecognized outside endemic regions despite being a leading cause of fever in travellers returning from sub-Saharan Africa. Its vectors, Amblyomma hebraeum and A. variegatum, have demonstrated ecological adaptability, and sporadic reports of exotic ticks and R. africae detection in Europe highlight the importance of clinical awareness and surveillance. While the gltA gene provided reliable species-level identification in this clinical context, additional loci such as ompB may offer improved resolution for future studies within the spotted fever group.
CONCLUSIONS: This case illustrates the typical clinical presentation and diagnostic approach to ATBF in a European traveller. Although it represents an imported travel-associated infection rather than evidence of local transmission, it underscores the importance of clinical awareness and integrated surveillance within a One Health framework.
CASE PRESENTATION: report a 48-year-old woman presenting with fever, headache, myalgia, abdominal pain, and multiple eschars after a 9-day trip to South Africa. Clinical examination revealed fever (38.5 °C), tender inguinal lymphadenopathy, and a maculopapular rash. Laboratory findings showed elevated C-reactive protein (45.4 mg/L) and mild monocytosis. Molecular analysis of eschar samples detected Rickettsia DNA, subsequently identified as R. africae. The patient was treated with oral doxycycline (200 mg/day) with rapid clinical improvement.
DISCUSSION: ATBF remains underrecognized outside endemic regions despite being a leading cause of fever in travellers returning from sub-Saharan Africa. Its vectors, Amblyomma hebraeum and A. variegatum, have demonstrated ecological adaptability, and sporadic reports of exotic ticks and R. africae detection in Europe highlight the importance of clinical awareness and surveillance. While the gltA gene provided reliable species-level identification in this clinical context, additional loci such as ompB may offer improved resolution for future studies within the spotted fever group.
CONCLUSIONS: This case illustrates the typical clinical presentation and diagnostic approach to ATBF in a European traveller. Although it represents an imported travel-associated infection rather than evidence of local transmission, it underscores the importance of clinical awareness and integrated surveillance within a One Health framework.